The following bibliography comprises a selection from 1992 articles from the world literature on antibi- otic resistance, infections of the urinary tract, infections in cystic fibrosis, infections with resistant strains of Enterococcus faecium, and infections with Pseudomonas aeruginosa, and home intravenous
antibiotic therapy.
Antibiotic resistance
Skin, soft tissue, and bone infections due to Myco- bacterium chelonae chelonae: Importance of prior corti- costeroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithro- mycin. Wallace R.J. Jr, Brown B.A., Onyi G.O. J.INFECT.DIS., 1992, Vol/Iss/Pg. 166/2 (405-412), ISSN: 0022-1899.
Antimicrobial resistance in Streptococcus pneumoniae: An epidemiological survey in France, 1970-1990. Geslin P., Buu-Hoi A., Fremaux A., Acar J.F. CLIN.INFECT.DIS., 1992, Vol/Iss/Pg. 15/1 (95-98), ISSN: 1058-4838.
Structure and function of the uhp genes for the sugar phos- phate transport system in Escherichia coli and Salmonella typhimurium. Island M.D., Wei B.Y., Kadner R.J. J.BACTERIOL., 1992, Vol/Iss/Pg. 174/9 (2754-2762), ISSN: 0021-9193.
A spontaneous chromosomal amplification of the ADH2 gene in Saccharomyces cerevisiae. Paquin C.E., Dorsey M., Crable S., Sprinkel K., Sondej M., Williamson V.M. GENETICS, 1992, Vol/Iss/Pg. 130/2 (263-271), ISSN: 0016-6731.
Eflornithine treatment of refractory Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Paulson Y.J., Gilman T.M., Heseltine P.N.R., Sharma O.P., Boylen C.T. CHEST, 1992, Vol/Iss/Pg. 101/1 (67-74), ISSN: 0012-3692.
Prevalence of transposons encoding kanamycin, ampi- cillin and trimethoprim resistance in isolated from urinary tract infections detected using DNA probes. Chang S.F., Chang L.L., Chow T.Y., Wu W.J., Chang J.C. K A O H S I U N G J.MED.SCI., 1992, Vol/Iss/Pg. 8/3 (141- 147), ISSN: 0257-5655.
Aminoglycoside class review. Robinson E.N. Jr. PROBL.CRIT.CARE, 1992, Vol/Iss/Pg. 6/1 (149-158), ISSN: 0889-4701.
Quinolone use in critical care. Piper J.P., Chang G.L. PROBL.CRIT.CARE, 1992, ISSN: 0889-4701.
Vol/Iss/Pg. 6/1 (64-83),
Infections of the urinary tract
An approach to evaluating antibacterial agents in the treat- ment of urinary tract infection.
Bacterial ecology of urinary infections in a specialized hos- pital and resistance to antibiotics. Comparison between the general hospital and the town. Pollet-Fondeur C., Robert H., Denis C., Bonenfant C.,
The emergence of highly fluoroquinolone-resistant Es- cherichia coli in community-acquired urinary tract infec- tions (4). Aguiar J., Chacon J., Canton R., Baquero F. J.ANTIMICROB.CHEMOTHER., 1992, Vol/Iss/Pg. 29/ 3 (349-350), ISSN: 0305-7453.
Prevalence of a plasmid-mediated type II dihydrofolate re- ductase gene among trimethoprim-resistant urinary path- ogens in Greek hospitals. Tsakris A., Vatopoulos A.C., Johnson A.P., Pitt T.L., Le- gakis N.J., Tzouvelekis L.S. J.ANTIMICROB.CHEMOTHER., 1992, Vol/Iss/Pg. 29/ 4 (405-413), ISSN: 0305-7453.
Bactrimregistered trade mark after 5 years: A present-day antibiotic. MED.MAL.INFECT., 1992, Vol/Iss/Pg. 22/3 (420), ISSN: 0399-077X.
Group B Streptococcus: A cause of urinary tract infection in nonpregnant adults. Munoz P., Coque T., Rodriguez-Creixems M., Bernaldo- de-Quiros J.C.L, Moreno S., Bouza E. CLIN.INFECT.DIS., 1992, Vol/Iss/Pg. 14/2 (492-496), ISSN: 1058-4838.
Controversial issues in the management of urinary tract infections. Gluckman S.J., DiNubile M.J. CURR.OPIN.INFECT.DIS., 1992, Vol/Iss/Pg. 5/1 (50- 56), ISSN: 0951-7375.
Infections in cystic fibrosis
Prenatal screening for cystic fibrosis. Mennie M.E., Gilfillan A., Compton M., Curtis L., Liston W.A., Pullen I., Whyte D.A., Brock D.J.H. LANCET, 1992, Vol/Iss/Pg. 340/8813 (214-216), ISSN: 0140-6736, Adonis No: 0140673692016572.
Affinity constants of naturally acquired and vaccine-in-
duced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients. Bruderer U., Cryz S.J. Jr, Schaad U.B., Deusinger M., Que J.U., Lang A.B. J.INFECT.DIS., 1992, Vol/Iss/Pg. 166/2 (344-349), ISSN: 0022-1899.
Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients. Bingen E., Denamur E., Picard B., Goullet P., Lambert- Zechovsky N., Foucaud P, Navarro J., Elion J. EUR.J.CLIN.MICROBIOL.INFECT.DIS., 1992, Vol/ Iss/Pg. 11/5 (432-437), ISSN: 0934-9723.
Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chroni- cally infected cystic fibrosis patients. Kronborg G., Fomsgaard A., Galanos C., Freudenberg M.A., Hoiby N. J.CLIN.MICROBIOL., 1992, Vol/Iss/Pg. 30/7 (1848- 1855), ISSN: 0095-1137.
Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Saiman L., Cacalano G., Gruenert D., Prince A. INFECT.IMMUN., 1992, Vol/Iss/Pg. 60/7 (2808-2814), ISSN: 0019-9567.
Production of the Pseudomonas aeruginosa neuramini- dase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. Cacalano G., Kays M., Saiman L., Prince A. J.CLIN.INVEST., 1992, Vol/Iss/Pg. 89/6 (1866-1874), ISSN: 0021-9738.
Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: A comparison between postural drainage, PEP and physical exercise. Lannefors L., Wollmer P. EUR.RESPIR.J., 1992, Vol/Iss/Pg. 5/6 (748-753), ISSN: 0903-1936, Adonis No: 0903193692001508.
Regulation of CFTR expression and function during dif- ferentiation of intestinal epithelial cells. Sood R., Bear C., Auerbach W., Reyes E., Jensen T., Kart- ner N., Riordan J.R, Buchwald M. EMBO.J., 1992, Vol/Iss/Pg. 11/7 (2487-2494), ISSN: 0261- 4189.
Quantitative analysis of immunoglobulin G subclass re- sponses to Pseudomonas aeruginosa antigens in cystic fi- brosis. Likavcanova E., Lagace J. J.MED.MICROBIOL., 1992, Vol/Iss/Pg. 36/6 (437-444), ISSN: 0022-2615, Adonis No: 0022261592001355.
IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis. Cordon S.M., Elborn J.S., Rayner R.J., Hiller E.J., Shale D.J. ARCH.DIS.CHILD, 1992, Vol/Iss/Pg. 67/6 (737-740), ISSN: 0003-9888, Adonis No: 000398889200267H.
Investigation of nephrotoxicity of amikacin in cystic fibro- sis patients. Hugli R., Artho G., Wiesmann U.N., Peheim E., Schaad U.B., Bianchetti M.G. SCHWEIZ.MED.WOCHENSCHR., 1992, Vol/Iss/Pg. 122/24 (930-935), ISSN: 0036-7672.
Intermediate-term results of heart-lung transplantation for cystic fibrosis. Madden B.P., Hodson M.E., Tsang V., Radley-Smith R., Khaghani A., Yacoub M.Y. LANCET, 1992, Vol/Iss/Pg. 339/8809 (1583-1587), ISSN: 0140-6736, Adonis No: 014067369201436P.
Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis. Taylor R.F.H., Morgan D.W., Nicholson P.S., Mackay I.S., Hodson M.E., Pitt T.L. THORAX, 1992, Vol/Iss/Pg. 47/6 (426-428), ISSN: 0040- 6376, Adonis No: 0040637692003598.
Comparison of four procedures for measuring elastase production by Pseudomonas aeruginosa strains from cys- tic fibrosis patients. Saulnier J., Wallach J.M., Doring G., Malissard M., Va- cheron M.J., Guinand M. EUR.J.CLIN.CHEM.CLIN.BIOCHEM., 1992, Vol/Iss/ Pg. 30/5 (285-290), ISSN: 0939-4974.
A 1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells. Eidelman O., Guay-Broder C., Van Galen P.J.M., Jacob- son K.A., Fox C., Turner R.J., Cabantchik Z,I., Pollard H.B. PROC.NATL.ACAD.SCI.USA, 1992, Vol/Iss/Pg. 89/12 (5562-5566), ISSN: 0027-8424.
275
Effects of mucoid and non-mucoid Pseudomonas aerugi- nosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear gran- ulocytes and rat mast cells. Friedl P., Konig B., Konig W. IMMUNOLOGY, 1992, Vol/Iss/Pg. 76/1 (86-94), ISSN: 0019-2805, Adonis No: 001928059200161X.
Home intravenous antibiotic treatment of patients with cystic fibrosis. Strandvik B., Hjelte L., Malmborg A.S., Widen B. ACTA PAEDIATR.INT.J.PAEDIATR., 1992, Vol/Iss/ Pg. 81/4 (340-344), ISSN: 0803-5253, Adonis No: 0803525392000820.
Modification of some markers of inflammation during treatment for acute respiratory exacerbation in cystic f - brosis. Valletta E.A., Rigo A., Bonazzi L., Zanolla L., Mastella G. ACTA PAEDIATR.INT.J.PAEDIATR., 1992, Vol/Iss/ Pg. 81/3 (227-230), ISSN: 0803-5253.
Auxotrophy of Pseudomonas aeruginosa in cystic fibrosis. Taylor R.F.H., Hodson M.E., Pitt T.L. FEMS.MICROBIOL.LETT., 1992, Vol/Iss/Pg. 92/3 (243- 246), ISSN: 0378-1097, Adonis No: 037810979200127B.
Down-regulation of cystic fibrosis transmembrane con- ductance regulator gene expression by agents that modu- late intracellular divalent cations. Bargon J., Trapnell B.C., Chu C.S., Rosenthal E.R., Yoshimura K., Guggino W.B., Dalemans W., Pavirani A., Lecocq J.P., Crystal R.G. MOL.CELL.BIOL., 1992, Vol/Iss/Pg. 12/4 (1872-1878), ISSN: 0270-7306.
Human tracheobronchial mucin: Purification and binding to Pseudomonas aeruginosa. Reddy M.S. INFECT.IMMUN., 1992, Vol/Iss/Pg. 60/4 (1530-1535), ISSN: 0019-9567.
In vitro activity of teicoplanin compared with vancomycin against methicillin-resistant Staphylococcus aureus de- rived from cystic fibrosis sputum. Arrieta A.C., Stutman H.R., Akaniro-J-C, Vargas-O-M. SO DIAGN-MICROBIOL-INFECT-DIS, 1992, Vol/Iss/ Pg. 15/3 (247-251), ISSN: 0732-8893, Adonis No: 0732889392000498.
The effect of amiloride on pigment expression in a clinical isolate of Pseudomonas aeruginosa.
AlgR2 is an ATP/GTP-dependent protein kinase involved in alginate synthesis by Pseudomonas aeruginosa. Roychoudhury S., Sakai K., Chakrabarty A.M. PROC.NATL.ACAD.SCI.USA, 1992, Vol/Iss/Pg. 89/7 (2659-2663), ISSN: 0027-8424.
Lung involvement, the DeltaF508 mutation and DNA haplotype analysis in cystic fibrosis. Santamaria F., Salvatore D., Castiglione O., Raia V., de Ritis G., Sebastio G. HUM.GENET., 1992, Vol/Iss/Pg. 88/6 (639-641), ISSN: 0340-6717.
Signal transduction in exopolysaccharide alginate synthe- sis: Phosphorylation of the response regulator AIgR1 in Pseudomonas aeruginosa and Escherichia coli. Roychoudhury S., Sakai K., Schlictman D., Chakrabarty A.M. GENE, 1992, Vol/Iss/Pg. 112/1 (45-51), ISSN: 0378-1119, Adonis No: 037811199200133P.
Temocillin and cystic fibrosis: Outcome of intravenous ad- ministration in patients infected with Pseudomonas ce- pacia. Taylor R.F.H., Gaya H., Hodson M.E. J.ANTIMICROB.CHEMOTHER., 1992, Vol/Iss/Pg. 29/ 3 (341-344), ISSN: 0305-7453.
Itraconazole in systemic aspergillosis: Experience in 22 cases. Pannelier C., Vienet A., Chwetzoff E. CHEMOTHERAPY (SWITZERLAND), 1992, Vol/Iss/ Pg. 38/SUPPL. 1 (54), ISSN: 0009-3157.
The quinolones. An overview of their pharmacology. Fitton-A. CLIN.PHARMACOKIN., 1992, Vol/Iss/Pg. 22/SUPPL. 1 (1-11), ISSN: 0312-5963.
Supplemental oxygen and exercise performance in patients with cystic fibrosis with severe pulmonary disease. Marcus C.L., Bader D., Stabile M.W., Wang C.I., Osher A.B., Keens T.G. CHEST, 1992, Vol/Iss/Pg. 101/1 (52-57), ISSN: 0012-3692.
Binding of nonmucoid Pseudomonas aeruginosa to nor- mal human intestinal mucin and respiratory mucin from patients with cystic fibrosis. Sajjan U., Reisman J., Doig P., Irvin R.T., Forstner G., Forstner J. J.CLIN.INVEST., 1992, Vol/Iss/Pg. 89/2 (657-665), ISSN: 0021-9738.
Binding of Pseudomonas cepacia to normal human intesti- nal mucin and respiratory mucin from patients with cystic fibrosis. Sajjan U.S., Corey M., Karmali M.A., Forstner J.F. J.CLIN.INVEST., 1992, Vol/Iss/Pg. 89/2 (648-656), ISSN: 0021-9738.
High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment. Giwercman B., Meyer C., Lambert P.A., Reinert C., Hoiby N. ANTIMICROB.AGENTS CHEMOTHER., 1992, Vol/ Iss/Pg. 36/1 (71-76), ISSN: 0066-4804.
Pseudomonas aeruginosa is retained in the bronchi of cys- tic fibrotics by the increased transepithelial potential. Dealler S.F., Holton A. MED.HYPOTHESES, 1992, Vol/Iss/Pg. 37/3 (186-190), ISSN: 0306-9877, Adonis No: 030698779200073S.
Controlled study of Pseudomonas cepacia and Pseudo- monas maltophilia in cystic fibrosis. Gladman G., Connor P.J., Williams R.F., David T.J. ARCH.DIS.CHILD, 1992, Vol/Iss/Pg. 67/2 (192-195), ISSN: 0003-9888, Adonis No: 000398889200093E.
Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibro- sis in Denmark. Johansen H.K, Hoiby N. THORAX, 1992, Vol/Iss/Pg. 47/2 (109-111), ISSN: 0040- 6376, Adonis No: 0040637692000482.
Epithelial respiratory cells from cystic fibrosis patients do not possess specific Pseudomonas aeruginosa-adhesive properties. Plotkowski M.C., Chevillard M., Pierrot D., Altemayer D., Puchelle E.
Factors for glucose intolerance in cystic fibrosis. Robert J.J., Grasset E., De Montalembert M., Chevenne D., Deschamps I., Boitard-C, Lenoir G. ARCH.FR.PEDIATR., 1992, Vol/Iss/Pg. 49/1 (17-22), ISSN: 0003-9764.
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Pedersen S.S., Hoiby N., Espersen F., Koch C. THORAX, 1992, Vol/Iss/Pg. 47/1 (6-13), ISSN: 0040- 6376, Adonis No: 0040637692000228.
Resistance to ciprofloxacin of respiratory pathogens in pa- tients with cystic fibrosis. Dostal R.E., Seale J.P., Yan. B.J. MED.J.AUST., 1992, Vol/Iss/Pg. 156/1 (20-24), ISSN: 0025-729X.
Infections with resistant strains of Enterococcusfaecium
Identical genes confer high-level resistance to gentamicin upon Enterococcus faecalis, Enterococcus faecium, and Streptococcus agalactiae. Kaufhold A., Podbielski A., Horaud T., Ferrieri P. ANTIMICROB.AGENTS CHEMOTHER., 1992, Vol/ Iss/Pg. 36/6 (1215-1218), ISSN: 0066-4804.
Isolation of a beta-lactamase-producing, aminoglycoside- resistant strain of Enterococcus faecium. Coudron P.E., Markowitz S.M., Wong E.S. ANTIMICROB.AGENTS CHEMOTHER., 1992, Vol/ Iss/Pg. 36/5 (1125-1126), ISSN: 0066-4804.
The VanS-VanR two-component regulatory system con- trois synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. Arthur M., Molinas C., Courvalin P. J.BACTERIOL., 1992, Vol/Iss/Pg. 174/8 (2582-2591), ISSN: 0021-9193.
Evidence for in vivo incorporation of D-lactate into pepti- doglycan precursors of vancomycin-resistant enterococci. Arthur M., Molinas C., Bugg T.D.H., Wright G.D., Walsh C.T., Courvalin P. ANTIMICROB.AGENTS CHEMOTHER., 1992, Vol/ Iss/Pg. 36/4 (867-869), ISSN: 0066-4804.
277
High-level resistance to gentamicin in Enterococcus fae- cium. Woodford N., McNamara E., Smyth E., George R.C. J.ANTIMICROB.CHEMOTHER., 1992, Vol/Iss/Pg. 29/ 4 (395-403), ISSN: 0305-7453.
Chlorhexidine sensitivity of Enterococcus faecium resis- tant to vancomycin, high levels of gentamicin, or both (2). Baillie L.W.J., Wade J.J., Casewell M.W. J.HOSP.INFECT., 1992, Vol/Iss/Pg. 20/2 (127-128), ISSN: 0195-6701.
A truncated Tn916-like element in a clinical isolate of En- terococcus faecium. Fletcher H.M., Daneo Moore L. PLASMID, 1992, Vol/Iss/Pg. 27/2 (155-160), ISSN: 0147- 619X.
Concomitant high-level vancomycin and penicillin resis- tance in clinical isolates of enterococci. Handwerger S., Perlman D.C., Altarac D., McAuliffe V. CLIN.INFECT.DIS., 1992, Vol/Iss/Pg. 14/3 (655-661), ISSN: 1058-4838.
Inducible carboxypeptidase activity in vancomycin-resis- tant enterococci. Gutmann L., Billot-Klein D., A1-Obeid S., Klare I., Fran- coual S., Collatz E., Van Heijenoort J. ANTIMICROB. AGENTS CHEMOTHER., 1992, Vol/ Iss/Pg. 36/1 (77-80), ISSN: 0066-4804.
Enterococcus faecium strains susceptible to ampicillin (1). Stewart D., Gray J.W., Pedler S.J. J.ANTIMICROB.CHEMOTHER., 1992, Vol/Iss/Pg. 29/ 1 (79), ISSN: 0305-7453.
Replacement of the essential penicillin-binding protein 5 by high-molecular mass PBPs may explain vancomycin- beta-lactam synergy in low-level vancomycin-resistant En- terococcus faecium D366. A10beid S., Billot Klein D., Van Heijenoort J., Collatz E., Gutmann L. FEMS.MICROBIOL.LETT., 1992, Vol/Iss/Pg. 91/1 (79- 84), ISSN: 0378-1097, Adonis No: 037810979200051N.
Pristinamycin for Enterococcus faecium resistant to van- comycin and gentamicin (26). Wade J., Baillie L., Rolando N., Casewell M. LANCET, 1992, Vol/Iss/Pg. 339/8788 (312-313), ISSN: 0140-6736, Adonis No: 0140673692003383.
278
Infections with Pseudomonas aeruginosa
Affinity constants of naturally acquired and vaccine-in- duced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patients. Bruderer U., Cryz S.J. Jr, Schaad U.B., Deusinger M., Que J.U., Lang A.B. J.INFECT.DIS., 1992, Vol/Iss/Pg. 166/2 (344-349), ISSN: 0022-1899.
Safety, immunogenicity, and efficacy of a Plasmodium fal- ciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aerugi- nosa toxin A. Fries L.F., Gordon D.M., Schneider I., Beier J.C., Long G.W., Gross M., Que J.U., Cryz S.J., Sadoff J.C. INFECT.IMMUN. 1992, Vol/Iss/Pg. 60/5 (1834-1839), ISSN: 0019-9567.
Production and characterisation of mouse monoclonal an- tibodies reactive with the lipopolysaccharide core of Pseu- domonas aeruginosa. Nelson J.W., Barclay G.R., Micklem L.R., Poxton I.R., Govan J.R.W. J.MED.MICROBIOL., 1992, Vol/Iss/Pg. 36/5 (358-365), ISSN: 0022-2615, Adonis No: 0022261592000551.
Intranasal immunization with bacterial polysaccharide containing liposomes enhances antigen-specific pulmo- nary secretory antibody response. Abraham E.
Properties determining the potential of naturally occurring and vaccine-induced human antibodies to protect against lethal infection of Pseudomonas aeruginosa. Bruderer U., Furer E., Cryz S.J. Jr, Lang A.B. RES.IMMUNOL., 1992, Vol/Iss/Pg. 143/2 (165-174), ISSN: 0923-2494, Adonis No: 0923249492000573.
A diphasic immune response against bacteria in the Ameri- can cockroach. Faulhaber L.M., Karp R.D. IMMUNOLOGY, 1992, Vol/Iss/Pg. 75/2 (378-381), ISSN: 0019-2805, Adonis No: 001928059200091L.
Local IgA and IgG response to intratracheal immuniza- tion with Pseudomonas aeruginosa antigens. Krogh-Johansen H., HoibyN. APMIS, 1992, Vol/Iss/Pg. 100/1 (87-90), ISSN: 0903-4641, Adonis No: 090346419200024J.
Home intravenous antibiotic therapy
Home intravenous antibiotic treatment of patients with cystic fibrosis. Strandvik B., Hjelte L., Malmborg A.S., Widen B. ACTA.PAEDIATR.INT.J.PAEDIATR., 1992, Vol/Iss/ Pg. 81/4 (340-344), ISSN: 0803-5253, Adonis No: 0803525392000820.
